p53 immunohistochemistry in endometrial cancer: clinical and …
Jun 25, 2022 · Article Open access Published: 25 June 2022 p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial Lisa Vermij, Alicia …
Tests Used on Biopsy and Cytology Samples to Diagnose and Classify Cancer
Here are some of the more common lab tests and procedures done on biopsy or cytology samples. To learn more about the tests that might be done for a specific kind of cancer, see …
p53 immunohistochemistry in endometrial cancer: clinical and …
Standard molecular classification of endometrial cancers (EC) is now endorsed by the WHO and identifies p53-abnormal (p53abn) EC as the subgroup with the poorest prognosis and the most …
Immunohistochemical Stains - Labcorp
Immunohistochemical Stains ... To ensure specimen integrity during warm weather, follow these Instructions for Use of frozen gel packs and specimen lockboxes.
p53 Immunohistochemical Staining and TP53 Gene Mutations in …
Oct 1, 2023 · Whether immunohistochemistry (IHC) of p53 accurately reflects the TP53 mutational status of endometrial carcinoma (EC) has not yet been established. This study aimed to clarify …
Immunohistochemistry (IHC) Stain: Purpose, Principle & Protocol
Dec 20, 2023 · Immunohistochemistry Staining (IHC) Introduction Immunohistochemistry (IHC) staining is a powerful technique that allows us to peek into the intricate world of protein …
p53 immunohistochemistry in endometrial cancer: clinical and …
Oct 1, 2022 · Standard molecular classification of endometrial cancers (EC) is now endorsed by the WHO and identifies p53-abnormal (p53abn) EC as the subgroup with the poorest …
p53 Immunohistochemistry staining patterns and prognosis …
Nov 1, 2024 · To investigate the immunohistochemistry (IHC) staining pattern and prognostic significance of p53 in non-endometrioid endometrial cancer (non-EEC).Thi…
Metastatic prostate cancer diagnosed by fine‐needle aspiration ...
Oct 20, 2022 · Introduction The diagnosis of metastatic prostatic cancer (MPC) by fine needle aspiration (FNA) can usually be rendered by typical cytomorphologic and …
C5b-9 Staining Correlates With Clinical and Tumor Stage in …
Aug 9, 2016 · Upregulated expression of C5b-9 has been noted on tumor cells in a multitude of various cancer types, such as cervical carcinomas 12, 13 and ovarian cancers, 14 - 16 and the …
Immunohistochemical correlates of TP53 somatic mutations in cancer …
Sep 8, 2016 · Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing …
Useful Immunohistochemical Markers of Tumor Differentiation
Abstract Immunohistochemistry (IHC) has been somewhat underutilized in the practice of toxicological pathology but can be a valuable tool for the evaluation of rodent neoplasms, both …
p53 immunohistochemistry in endometrial cancer: clinical and …
Abstract Standard molecular classification of endometrial cancers (EC) is now endorsed by the WHO and identifies p53-abnormal (p53abn) EC as the subgroup with the poorest prognosis …
Few data are available about the immunohistochemical expression of this marker in molecular types of breast cancer and to its potential contribution in stratification of patients based on …